News tagged with cancer drugs
Related topics: cancer , cells , cancer cells
News of plaque-clearing drug tops week of major advances against Alzheimer's disease
In the last eight days, scientists have delivered a powerful one-two punch in the fight to defeat Alzheimer's disease. At the same time, the White House and members of Congress are proposing increases in Alzheimer's research ...
Feb 10, 2012 |
5 / 5 (3) |
1
Short fasting cycles work as well as chemotherapy in mice
Man may not live by bread alone, but cancer in animals appears less resilient, judging by a study that found chemotherapy drugs work better when combined with cycles of short, severe fasting.
Feb 08, 2012 |
4.7 / 5 (14) |
3
|
Discovery predicts patient sensitivity to important drug target in deadly brain cancer
A recent discovery by Van Andel Research Institute (VARI) scientists enables the prediction of patient sensitivity to proposed drug therapies for glioblastoma – the most common and most aggressive malignant brain tumor ...
Feb 06, 2012 |
4 / 5 (2) |
0
|
Three 'targeted' cancer drugs raise risk of fatal side effects
Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that ...
Feb 06, 2012 |
5 / 5 (1) |
0
|
A silver bullet to beat cancer?
The internet is awash with stories of how silver can be used to treat cancer. Now, lab tests have shown that it is as effective as the leading chemotherapy drug - and may have fewer side-effects.
Feb 02, 2012 |
5 / 5 (3) |
0
|
FDA approves new skin cancer drug
A new skin cancer drug tested for the first time in the world five years ago at the Virginia G. Piper Cancer Center at Scottsdale Healthcare just received expedited approval by the U.S. Food and Drug Administration, a remarkable ...
Feb 01, 2012 |
not rated yet |
0
New drug extends survival in patients with drug-resistant prostate cancer
A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular receptor that drives progression ...
Feb 01, 2012 |
5 / 5 (1) |
0
|
Researchers develop novel drug delivery system
Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery. ...
Jan 31, 2012 |
5 / 5 (2) |
0
Cancer drugs shown to cause mutations in mice offspring
(Medical Xpress) -- For many years, most of the studies done to see what effects cancer treatment has on the offspring of survivors, has involved radiation. This is because radiation is known to cause mutations in cells. ...
Jan 31, 2012 |
4 / 5 (2) |
0
|
FDA approves Roche skin cancer drug Erivedge
(AP) -- Federal regulators on Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma.
Medicine & Health / Medications
Jan 30, 2012 |
not rated yet |
0
Stress-induced genomic instability facilitates rapid cellular adaption in yeast
Cells trying to keep pace with constantly changing environmental conditions need to strike a fine balance between maintaining their genomic integrity and allowing enough genetic flexibility to adapt to inhospitable conditions. ...
Jan 29, 2012 |
5 / 5 (1) |
0
|
UT researchers' innovation addresses major challenge of drug delivery
A new physical form of proteins developed by researchers at The University of Texas at Austin could drastically improve treatments for cancer and other diseases, as well as overcome some of the largest challenges in therapeutics: ...
Nanotechnology / Bio & Medicine
Jan 28, 2012 |
5 / 5 (2) |
0
FDA clears Pfizer drug for advanced kidney cancer
(AP) -- The Food and Drug Administration has approved a new Pfizer drug for patients with advanced kidney cancer that has spread to other parts of the body despite treatment with at least one previous drug.
Medicine & Health / Medications
Jan 27, 2012 |
5 / 5 (2) |
0
Erlotinib dose-adjusted for smoking status effective as first treatment for head and neck cancer
Head and neck cancers respond well to the anti-cancer drug erlotinib when it is administered before surgery and a stronger dose is given to patients who smoke, according to a study presented at the Multidisciplinary Head ...
Jan 26, 2012 |
not rated yet |
0
'DIMming' cancer growth -- STAT: Diindolylmethane suppresses ovarian cancer
Ovarian cancer is a major cause of death worldwide. Approximately 25,000 women will be diagnosed with ovarian cancer this year and 15,000 women will die from it in the United States alone. The novel anti-cancer drug diindolylmethane ...
Jan 26, 2012 |
not rated yet |
1
